Free tool

Cell therapy stocks

We cover 19 companies grouped under the Cell therapy theme. The median market value in the group is $513.95M. Across the group, the median move over the past trading day is −0.88%. Price change over the past year runs from −12.6% to +158.7% across the middle 80 percent of the group, with a median of +37.3%.

Other lists in this group

Table

19 of 86 companies match these filters.Clear filters

TickerCompanyMarket cap (USD)Size1Y return
VORVor Biopharma Inc.$1.30BSmall cap−40.82%
SANASana Biotechnology, Inc.$1.25BSmall cap+23.44%
CYRXCryoport, Inc.$839.26MSmall cap+88.94%
ALLOAllogene Therapeutics, Inc.$704.80MSmall cap+75.86%
PROKProKidney Corp.$694.58MSmall cap−30.12%
AUTLAutolus Therapeutics plc$620.16MSmall cap+48.41%
ARTVArtiva Biotherapeutics, Inc.$575.44MSmall cap+259.94%
KYTXKyverna Therapeutics, Inc.$546.70MSmall cap+133.33%
CABACabaletta Bio, Inc.$545.94MSmall cap+116.67%
CAPRCapricor Therapeutics, Inc.$481.97MSmall cap+49.76%
IPSCCentury Therapeutics, Inc.$392.93MSmall cap+315.53%
LYELLyell Immunopharma, Inc.$362.68MSmall cap+37.32%
CLLSCellectis S.A.$344.40MSmall cap+28.09%
RNACCartesian Therapeutics, Inc.$308.30MSmall cap−4.09%
FATEFate Therapeutics, Inc. Common Stock$305.54MSmall cap+129.46%
LCTXLineage Cell Therapeutics, Inc.$283.26MSmall cap−8.20%
NKTXNkarta, Inc.$194.10MSmall cap+17.41%
MXCTMaxCyte, Inc.$139.33MSmall cap−6.43%
DTSQUDT Cloud Star Acquisition CorporationSmall cap+9.95%

Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.

More ways to browse